This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Main Street Tax Certainty Act

Educational Choice for Children Act of 2025

Educational Choice for Children Act of 2025

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

REVIVE VI Act Restore Economic Vitality and Investment in the Virgin Islands Act

ORPHAN Cures Act Optimizing Research Progress Hope And New Cures Act

Fair Access to Banking Act

Proposing an amendment to the Constitution of the United States to limit the number of terms that a Member of Congress may serve.

Student Empowerment Act

This resolution elects Members to the Committees on Agriculture; Foreign Affairs; Natural Resources; and Science, Space, and Technology.

This resolution provides for the House to attend the inaugural ceremonies of the President and Vice President of the United States on January 20, 2025, and, thereafter, for the House to stand adjourned until 12:00 p.m. (noon) on January 21, 2025.

Expressing support for the designation of June 11, 2025, as "World Franchise Day".

Electing Members to certain standing committees of the House of Representatives.